Symbyax

Symbyax is a combination of olanzapine, the active ingredient in Zyprexa, and fluoxetine, the active ingredient in Prozac. It is the first medication approved by the FDA the treatment of the depressive phase of bipolar disorder. Medication Profile | Side Effects